1. Home
  2. COLM vs RARE Comparison

COLM vs RARE Comparison

Compare COLM & RARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Columbia Sportswear Company

COLM

Columbia Sportswear Company

N/A

Current Price

$56.92

Market Cap

3.0B

ML Signal

N/A

Logo Ultragenyx Pharmaceutical Inc.

RARE

Ultragenyx Pharmaceutical Inc.

N/A

Current Price

$14.30

Market Cap

2.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
COLM
RARE
Founded
1938
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.6B
IPO Year
1997
2013

Fundamental Metrics

Financial Performance
Metric
COLM
RARE
Price
$56.92
$14.30
Analyst Decision
Buy
Strong Buy
Analyst Count
7
20
Target Price
$62.50
$59.10
AVG Volume (30 Days)
608.2K
3.5M
Earning Date
04-30-2026
05-05-2026
Dividend Yield
2.00%
N/A
EPS Growth
N/A
7.31
EPS
1.17
N/A
Revenue
$3,042,478,000.00
$673,000,000.00
Revenue This Year
$3.73
$13.12
Revenue Next Year
$3.29
$37.80
P/E Ratio
$47.91
N/A
Revenue Growth
N/A
20.13
52 Week Low
$47.48
$13.81
52 Week High
$69.06
$39.89

Technical Indicators

Market Signals
Indicator
COLM
RARE
Relative Strength Index (RSI) 38.83 20.38
Support Level $53.96 N/A
Resistance Level $56.49 $24.80
Average True Range (ATR) 1.39 0.94
MACD -0.04 -1.26
Stochastic Oscillator 16.80 3.82

Price Performance

Historical Comparison
COLM
RARE

About COLM Columbia Sportswear Company

Columbia Sportswear Co makes outdoor and active-lifestyle apparel, footwear, equipment, and accessories that it sells under four primary brands: Columbia, Sorel, Mountain Hardwear, and prAna. The majority of sales are in the United States, but the company also has remarkable sales in its three other geographic segments: Latin American and Asia-Pacific; Europe, Middle East, and Africa; and Canada. The majority of sales are through wholesale channels, including sporting goods and department stores, but the company also operates its own branded stores in each of its geographic segments. It sources products from around the world and uses contract manufacturers outside the United States, predominantly in Asia to manufacture its various products.

About RARE Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. The company identifies, acquires, develops, and commercializes novel products for the treatment of serious, rare, and ultra-rare diseases, with a focus on debilitating genetic conditions. Its medicine portfolio includes Crysvita, Dojolvi, and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients aged one year and older. Mepsevii is indicated for pediatric and adult patients for the treatment of Mucopolysaccharidosis VII. The company operates across North America, Latin America, Europe, the Middle East and Africa, and Asia-Pacific, with the majority of its revenue generated from North America.

Share on Social Networks: